Rx/Reimbursement Adult Incontinence in Australia

Rx/reimbursement adult incontinence in Australia saw volume and current value growth in 2023. The policy and pre-budget submission by the Continence Foundation of Australia for 2023-2024 continues to tackle the stigma and restrictions associated with incontinence. One significant initiative proposed is the implementation of a Capability Building Program for General Practice to enhance its role in referrals and support for individuals experiencing incontinence.

The Rx/Reimbursement adult incontinence in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2028 illustrate how the market is set to change.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Rx/Reimbursement adult incontinence market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.